EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Plasma-Derived Extracellular Vesicle microRNAs in Multiple Sclerosis: An Exploratory Case-Control Study on Phenotypic Discrimination

Oana Vrînceanu iD, Doina Manu iD, Smaranda Maier, Claudia Bănescu iD, Ana-Claudia Carstea, Rodica Bălașa

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177530 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Oana Vrînceanu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania. Hauptthemen laut MEDLINE: MicroRNAs, Extracellular Vesicles, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Distinguishing relapsing–remitting multiple sclerosis (RRMS) from secondary-progressive disease (SPMS) remains a clinical challenge, as no single laboratory test reliably identifies the transition. We explored whether plasma extracellular-vesicle (EV) microRNAs could separate the two phenotypes. Four candidate EV-miRNAs: miR-30a-5p, miR-223-5p, miR-155-5p, and miR-146a-5p, were quantified by qRT-PCR in plasma-derived EVs from 13 healthy controls (HC), 7 RRMS, and 16 SPMS patients, normalized to miR-16-5p. EVs were characterized by electron microscopy, dynamic light scattering, and zeta potential, confirming vesicles of expected morphology, size, and negative surface charge. Two miRNAs were informative. miR-155-5p was significantly downregulated in both RRMS and SPMS versus controls but did not differentiate the phenotypes (AUC 0.52), behaving as a disease-general marker. In contrast, miR-223-5p was selectively reduced in SPMS, to approximately one-quarter of control abundance, and provided the only signal distinguishing progressive from relapsing disease (AUC 0.73; rank-biserial −0.46). miR-30a-5p and miR-146a-5p were uninformative. These findings, consistent with the circulating/EV literature, suggest EV-miR-223-5p as a candidate marker of the progressive phenotype and EV-miR-155-5p as a disease indicator. Given the small cohort and near-detection-limit measurements, the study is hypothesis-generating and requires validation in larger, longitudinal cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExtracellular VesiclesMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingHumansFemaleCase-Control StudiesMaleAdultPhenotypeBiomarkersMiddle Aged

Stichwörter der Autor:innen

extracellular vesicle miRNAmultiple sclerosisphenotypeprogression

Substanzen

MicroRNAsBiomarkersMIRN146 microRNA, humanMIR223, humanMIRN155 microRNA, human

Autor:innen und Institutionen

  • Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
  • Center for Advanced Medical and Pharmaceutical Research, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
  • Department of Neurology, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540136 Targu Mures, Romania.
  • 1st Neurology Clinical, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania.

ORCID-Profile: Oana Vrînceanu, Doina Manu, Claudia Bănescu

Zitieren

APA

Vrînceanu, O., Manu, D., Maier, S., Bănescu, C., Carstea, A. C., & Bălașa, R. (2026). Plasma-Derived Extracellular Vesicle microRNAs in Multiple Sclerosis: An Exploratory Case-Control Study on Phenotypic Discrimination. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177530

Vancouver

Vrînceanu O, Manu D, Maier S, Bănescu C, Carstea AC, Bălașa R. Plasma-Derived Extracellular Vesicle microRNAs in Multiple Sclerosis: An Exploratory Case-Control Study on Phenotypic Discrimination. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177530

BibTeX
@article{Vrnceanu2026,
  author = {Vrînceanu, Oana and Manu, Doina and Maier, Smaranda and Bănescu, Claudia and Carstea, Ana-Claudia and Bălașa, Rodica},
  title = {Plasma-Derived Extracellular Vesicle microRNAs in Multiple Sclerosis: An Exploratory Case-Control Study on Phenotypic Discrimination},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177530}
}
Kostenlos starten →